379229-01-3

Basic information

• Product Name: 1H-Imidazole-1-ethanol,5-methyl-(9CI)
• Synonyms: 1H-Imidazole-1-ethanol,5-methyl-(9CI)
• CAS NO: 379229-01-3
• Molecular Formula: C6H10N2O
• Molecular Weight: 126.1564
• Product Categories: AMINETERTIARY
• Mol File: 379229-01-3.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: 1H-Imidazole-1-ethanol,5-methyl-(9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 1H-Imidazole-1-ethanol,5-methyl-(9CI)(379229-01-3)
• EPA Substance Registry System: 1H-Imidazole-1-ethanol,5-methyl-(9CI)(379229-01-3)

Safety Data

• Hazardous Substances Data: 379229-01-3(Hazardous Substances Data)

Usage

Derivative

Imidazole

Usage

Synthesis of pharmaceuticals and other organic compounds

Physical state

White solid at room temperature

Solubility

Soluble in water

Biological activity

Potential biological activity

Medical applications

Potential use in the development of new drugs and treatments

Upstream product

• 96-49-1 [1,3]-dioxolan-2-one 
• 822-36-6 4-methyl-1H-imidazole 
• 5437-45-6 Benzyl bromoacetate 

Relevant articles and documents

HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF SUMO ACTIVATING ENZYME

Disclosed are chemical entities which are compounds of formula (I); or pharmaceutically acceptable salts thereof; wherein Y, Ra, Ra', Rb, Rc, X1, X2, X3, Rd, Z1, and Z2 have the values described herein and stereochemical configurations depicted at asterisked positions indicate absolute stereochemistry. Chemical entities according to the disclosure can be useful as inhibitors of Sumo Activating Enzyme (SAE). Further provided are pharmaceutical compositions comprising a compound of the disclosure and methods of using the compositions in the treatment of proliferative, inflammatory, cardiovascular, and neurodegenerative diseases or disorders.

Monocyclic, substituted imidazoles as glycosidase inhibitors

A range of 4-monosubstituted and 2,4-disubstituted 1H-imidazoles and 1H-imidazole-1-ethanols (R-C(4): CH2CH2Ph, CHOHCH 2Ph, Ph, or Me; R-C(2): CH2OH, CHOHCH2OH, CN, or CH2NHAc) were prepare

Quinazoline derivatives

The invention concerns quinazoline derivatives of Formula (I) wherein each of m, R1, n, R2 and R3 have any of the meanings defined in the description; processes for their preparation, pharmaceutical compositions containing them and their use in the manufacture of a medicament for use as an anti-invasive agent in the containment and/or treatment of solid tumour disease.